Digital Health Startups

Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease. The test, derived from Stanford University research using omics platforms and AI, is provided to clinics, physicians, and healthcare providers to help manage patients' chronic inflammation and longevity.

4 investors

Eka Care is a personal health record (PHR) application that enables users to store medical records and monitor health vitals, serving patients and healthcare providers in India. The platform integrates with national health infrastructure including NDHM and CoWIN portals.

4 investors

ekincare operates a corporate health benefits platform that combines employee health management, risk prediction, and health insurance claims processing for employers in India. It serves companies and their workforces with health wallets, wellness programmes, benefits administration, and workforce health analytics covering over 2 million lives.

4 investors

Elemeno Health operates a platform providing digital health solutions for nursing and patient care. The company is backed by institutional investors and a crowdfunding community of healthcare professionals and patients.

4 investors

Elephant provides digital health infrastructure for public healthcare systems in low- and middle-income countries, offering an offline-capable EHR (ElephantOS), clinical guidance tools (Elephant Nudge), and an AI-driven platform to integrate third-party healthcare tools into clinical workflows.

4 investors

Ema is a clinical AI layer that runs on top of frontier models to add medical judgment, safety guardrails, and clinical rubrics for health and wellness products. It targets companies building AI features in care settings, with an emphasis on women's health, and turns user conversations into de-identified signals teams can act on.

4 investors

Emergency Response Africa provides mobile-enabled emergency medical dispatch and first responder training across Africa to reduce preventable deaths from sudden illness, accidents, and trauma. The service aims to improve emergency response capacity, reduce maternal and neonatal mortality, and support universal health coverage in lower-income countries.

4 investors

Empatica offers an FDA-cleared health monitoring platform combining medical wearables and digital biomarkers to collect continuous, clinical-quality health data from daily life. It serves researchers, clinicians, and pharmaceutical companies for clinical trials and remote patient monitoring across therapeutic areas including neurology and Parkinson's disease.

4 investors

EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies. It is built by a multidisciplinary team with experience in platform and commercial market development.

4 investors

Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes. Developed in partnership with Mayo Clinic, the therapy aims to help patients manage blood glucose levels and slow disease progression.

4 investors

EngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.

4 investors

EpilepsyGTx is a preclinical-stage biotech developing gene therapies for focal refractory epilepsy (FRE), with the aim of making patients seizure free.

4 investors

Erasca is a clinical-stage oncology company developing therapies targeting RAS- and MAPK pathway-driven cancers using a modality-agnostic approach including small molecules, large molecules, and protein degraders.

4 investors

Eucalyptus operates a group of digital healthcare clinics providing telehealth services to patients, focused on treating complex and chronic conditions and offering preventative care. The company runs consumer telehealth brands (such as Juniper) across multiple markets globally.

4 investors

Evergreen Nephrology partners with nephrologists to manage kidney care for patients with kidney disease, focusing on outcomes such as preventing hospitalizations, slowing disease progression, and increasing transplant rates. It operates a value-based kidney care model that supports physicians in coordinating care for their kidney patient populations.

4 investors

Everlab is a health platform offering preventative diagnostics, longevity testing (bloodwork, genetics, and fitness), and access to longevity-trained doctors, dietitians, and physios, with results and care plans tracked in a single app. It serves individual consumers seeking proactive and preventative healthcare across Australia.

4 investors

evolvedMD integrates behavioral health services into primary care settings to improve access to mental health treatment. The company serves primary care practices and their patients seeking integrated care for depression, anxiety, and other mental health conditions.

4 investors

EXCIVA is a privately held biotech company developing clinical-stage therapeutics for neuropsychiatric indications, with a focus on treating neuropsychiatric symptoms of dementia such as agitation and aggression in Alzheimer's disease. Its lead candidate, Deraphan, is in Phase 2/3 trials.

4 investors

Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema. The drug is set to enter Phase IIb clinical trials in 2026.

4 investors

Ezra offers advanced MRI-based full-body scans designed to screen for early signs of cancer and hundreds of other medical conditions. The service targets individuals seeking preventive health screening, with scans potentially eligible for HSA/FSA reimbursement.

4 investors

FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care. The company runs clinical trials across Europe and the US for people living with heart failure.

4 investors

Florence operates an AI-powered trial operations platform that connects research sites with sponsors and life science organizations to run clinical trials from startup through closeout. It offers tools for investigator site files, electronic trial master files, informed consent, contracting, monitoring, and long-term archiving for the clinical research industry.

4 investors

Floreo builds a library of immersive VR lessons designed to help develop social and behavioral regulation skills. Through its Floreo SkillsXP platform, families, therapists, and educators create individualized learning programs for use in and out of clinical settings.

4 investors

Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions. It targets acute care settings, supporting fluid management for patients with sepsis and septic shock.

4 investors